News AZ's asthma drug Fasenra approved in EU A further 3,400 children are eligible for treatment with Orkambi
News Spark divides opinion with $850,000 gene therapy Spark offers efficacy-based rebates and deferred payments to mitigate costs
News NHS should fund GSK's £526,000 "bubble baby" drug - NICE Strimvelis is most expensive drug cleared by NICE
Views & Analysis Patient involvement in HTA Considering the essential role of patient experience in HTA and the role of pharma.
News NICE to reassess Pfizer blood cancer drug Company successfully appealed against rejection last summer
Views & Analysis What is pharmaceutical market access? Findings from a comprehensive survey on the topic of market access.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
